Indeed recent studies show that BCL-2 is downregulated upon APC mutation and inhibition of Bcl-XL was shown to impair adenoma outgrowth, although BCL-XL inhibition was not effective on preexisting adenomas (43). The gene discussed is APC; the disease is adenoma.